Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Virus or component thereof
Patent
1994-03-18
1999-12-07
Duffy, Patricia A.
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Virus or component thereof
A61K 39245
Patent
active
059978805
ABSTRACT:
Herpes Zoster, or varicella related post herpetic neuralgia is alleviated by immunizing people at risk of developing herpes zoster with varicella zoster virus (VZV) antigen.
REFERENCES:
patent: 376788 (1888-07-01), Ellis
patent: 441737 (1890-11-01), Ellis
patent: 3985615 (1976-10-01), Kabo
patent: 4000256 (1976-12-01), Hilleman et al.
patent: 4008317 (1977-02-01), Gits et al.
patent: 4147772 (1979-04-01), McAleer et al.
patent: 4191745 (1980-03-01), Mayr et al.
patent: 4273762 (1981-06-01), McAleer et al.
patent: 4337242 (1982-06-01), Markus et al.
patent: 4338335 (1982-07-01), McAleer et al.
patent: 4686101 (1987-08-01), Ellis et al.
patent: 4769239 (1988-09-01), Elllis et al.
patent: 4812559 (1989-03-01), Ellis et al.
patent: 4952674 (1990-08-01), Keller et al.
patent: 5024836 (1991-06-01), McAleer et al.
Bennett, P.S. et al., "The Effects of Freeze-Drying on the Potency and Stability of Live Varicella Virus Vaccine," Develop. Biol. Standard, vol. 74: pp. 215-221 (1990).
Provost, P.J. et al., "Antibody Assays Suitable for Assessing Immune Responses to Live Varicella Vaccine," Vac., vol. 9, pp. 111-116 Feb. (1991).
Hardy, I., et al., "The Incidence of Zoster After Immunization with Live Attenuated Varicella Vaccine," New Eng. J. of Med., vol. 325; pp. 1545-1550 (1991).
Hayward, A., et al., "Varicella-Zoster Virus (VZV)-Specific Cytotoxicity after Immunization of Nonimmune Adults with Oka Strain . . . ," J. Infec. Dis., vol. 166; pp. 260-264 (1992).
Sperber, S. et al., "Seroligic Response and Reactogenicity to Booster Immunization of Healthy Seropositive Adults with Live or . . .," Antiviral Res. vol. 17; pp. 213-222 (1992).
Keller, P.M. et al., "Three Major Glucoprotein Genes of Varicella-Zoster Virus Whose Products Have Neutralization Epitopes," J. Virol., vol. 52; pp. 293-297 (1984).
Keller, P.M. et al., "Purification of Individual Varicella-Zoster Virus (VZV) Glycoproteins gpI, gpII, and gpIII and Their Use in ELISA . . .," J. Virol. Methods, vol. 14; pp. 177-188 (1986).
Davison, A. J. et al., "New Common Nomemclature for Glycoprotein Genes of Varicella-Zoster Virus and Their Glycosylated Products," J. Virol., vol. 57; pp. 1195-1197 (1986).
Neff, B.J. et al., "Clinical and Laboratory Studies of KMcC Strain Live Attentuated Varicella Virus," Proc. S. E. Bio. and Med., vol. 166; pp. 339-347 (1981).
Mayo & Booss, "Varicella Zoster-Associated Neurologic Disease Without Skin Lesions," Arch Neurol., vol. 46; pp. 313-315 (1989).
Gnann & Whitley, "Natural History and Treatment of Varicella-Zpster in High-Risk Populations," J. Hos. Infec., vol. 18; pp. 317-329 (1991).
Croen & Straus, "Varicella-Zoster Virus Latency," Annu. Rev. Microbiol., vol. 45, pp. 265-282 (1991).
Junker, A. et al., "Recurrent Varicella-Zoster Virus Infections in Apparently Immunocompetent Children," Ped. Infec. Dis. J., vol. 10; pp. 569-575 (1991).
Christiansen, N. P. et al., "Early Herpes Zoster Infection in Adult Patients with Hodgkin's Disease Undergoing Antologous Bone . . . " Bone Marrow Trans., vol. 7; pp. 435-437 (1991).
Vafai, A. et al., "Detection of Antibodies to Varicella-Zoster Virus Proteins in Sear from the Elderly," Gerontology, vol. 34; pp. 242-249 (1988).
Ragozzino, et al., "Risk of Cancer After Herpes Zoster," New Eng. J. Med., vol. 307; pp. 393-397 (1982).
Wilson, A., et al., "Subclinical Varicella-Zoster Virus Viremia,Herpes Zoster, and T Lymphocyte Immunity to Varicella-Zoster Viral . . . ," J. Infec. Dis., vol. 165; pp. 119-126 (1991).
Lawrence, R. et al., "The Risk of Zoster After Varicella Vaccination in Children with Leukemia," New Engl. J. Med., vol. 318; pp. 543-548 (1992).
Hardy, I., et al., "Zoster After Live Attenuated Varicella Vaccine," Abs. of the 1990 ICAAC No. 723.
Levin, J.J. et al., "Use of a Live, Attenuated Varicella-Zoster Virus (VZV) Vaccine to Boost the VZV Immune Responses of Eldrely Individuals," Abs. of the 1990 ICAAC No. 724.
Plotkin, S.A. et al., "Zoster in Normal Children After Varicella Vaccine," J. Infec. Dis., vol. 159; pp. 1000-1001 (1989).
Brunnell, P.A. et al., "Risk of Herpes Zoster in Children with Leukemia: Varicella Vaccine Compared with History of Chickenpox", Ped. vol. 77; pp. 53-56.
Antonelli, M. et al., "Herpes Zoster in Patients with Rheumatoid Arthritis Treated with Weekly, Low-Dose Methotrexate," Am. J. Med., vol. 90; pp. 295-298 (1991).
Schmader, K. et al., "Are Stressful Life Events Risk Factors for Herpes Zoster?," Am. Geriatrics Soc., vol. 38; pp. 1188-1194(1990).
Williams, D. L. et al., "Herpes Zoster Following Varicella Vaccine in a Dhild with Acute Lymphocytic Leukemia," J. Ped., vol. 106; pp. 259-261 (1985).
Ljungman, P. et al., "A Randomized Trial of Oral Versus Intravenous Acyclovir for Treatment of Herpes Zoster in Bone Marrow . . . ," Bone Marrow Trans., vol. 4; pp. 613-615 (1989).
Hammershlag, M. et al., "Herpes Zoster in an Adult Recipient of Live Attentuated Varicella Vaccine," J. Infec. Dis., vol. 160; pp. 535-537 (1989).
Yitzchak, F. et al., "Multiple Ischemic Infarcts in a Child with AIDS, Varicella Zoster Invection, and Cerebral Vasculitis," Ped. Neurology, vol. 5; pp. 64-67 (1988).
Gershon, A. A. et al., "Antibody to Varicella-Zoster Virus in Parturient Women and Their Offspring During the First Year of Life," Ped., vol. 58; pp. 692-696 (1976).
Lipton, S. and Brunnell P., "Management of Varicella Exposure in a Neonatal Intensive Care Unit," JAMA, vol. 261; pp. 1782-1784 (1989).
Duby, A., et al., "Sequestration of Virus-Specific T Cells in the Cerebrospinal Fluid of a Patient with Varicella Zoster Viral Meningoencephalitis," J. Of Neuroimm., vol. 22; pp. 63-68 (1989).
Leventon-Kriss, S. et al., "Seroepidemiologic Aspects of Varicella-Zoster Virus Infections in an Israeli Jewish Population," Israel J. Med. Sci., vol. 14; pp. 766-770 (1978).
Reboul, F. et al., "Herpes Zoster and Varicella Infections in Children with Hodgkin's Disease," Cancer, vol. 41; pp. 95-99 (1978).
Rusthoven, J. et al., "Varicella-Zoster Infection in Adult Cancer Patients . . .," Arch. Intern. Med., vol. 148; pp. 1561-1566 (1988).
Bolin & Koellner, "Airborne Transmission of Nosocomial Varicella from Localized Zoster," J. Infec. Dis., vol. 158; pp. 238-247 (1988).
Croen, K. et al., "Patterns of Gene Expression and Sites of Latency in Human Nerve Ganglia are Different for Varicella-Zoster . . .," Proc. Natl. Acad. Sci. USA, vol. 85; pp. 9773-9777 (1988).
Webster, A. et al., "Titration of IgG Antibodies Against Varicella Zoster Virus Before Cone Marrow Transplant Is Not Predictive . . .," J. Med. Virol., vol. 27; pp. 117-119 (1989).
Sperber, S. et al., "Varicella Vaccine Seen to Help Prevent Herpes in the Elderly . . .," Infec. Dis. News., vol. 2; p. 4 (1989).
Kobayashi, S. et al., "Varicella-Zoster Virus Infection in Chronic Granulomatous Disease," Ped. Infec. Dis., vol. 7; pp. 809-810 (1988).
Berger, R. et al., "Restoration of Varicella-Zoster Virus Cell-Mediated Immune Response After Varicella Booster Vaccination," Postgrad. Med. J., vol. 61; pp. 143-145 (1985).
Hayward, A. et al., "Varicella-Zoster Virus-Specific Immunity after Herpes Zoster," J. Infec. Dis., vol. 163; vol. 873-875 (1991).
Wei-hai, L. et al., "Experimental Studies on the Prevention and Treatment of Chickenpox and Herpes Zoster with Measles Vaccine," Chinese Med. J. vol. 102; pp. 395-399 (1989).
Peterslund, N., "Management of Varicella Zoster Infections in Immunocompetent Hosts," Am. J. Med., vol. 85; pp. 74-78 (1988).
Belfour, H., "Varicella Zoster Virus Infections in Immunocomprised Hosts," Am. J. Med 85; pp. 68-73 (1988).
Arvin, A., et al., "Immunologic Evidence of Reinfection with Varicella-Zoster Virus," J. Infec. Dis., vol. 148; pp. 200-205 (1983).
Luby, J. et al., "A Longitudinal Study of Varicella-Zoster Virus Infection in Renal Transplant Recipients," J. Infec. Dis., vol. 135; pp. 659-663 (1977).
Harper and Grose, "IgM and IgG Responses to Varicella-Zoster Virys p.32/p36 Complex After Chickenpox and Zoster, Congenital . . .," J. Infec. Dis., vol. 159; pp. 444-451 (1989).
Vafai, et al., "Expression of Varicella-Zoster Virus in Blood Mononuclear Cells of Patients with Postherpetic Ne
Calandra Gary B.
Levin Myron J.
Provost Philip J.
White C. Jo
Coppola Joseph A.
Duffy Patricia A.
Merck & Co. , Inc.
Tribble Jack L.
University of Colorado
LandOfFree
Method for alleviating varicella related post-herpetic neuralgia does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for alleviating varicella related post-herpetic neuralgia, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for alleviating varicella related post-herpetic neuralgia will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-820694